Fintel reports that on March 13, 2025, Citigroup initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Buy ...

Brook trout may have a genetic trick up their scales when it comes to adapting, with limitations, to heat waves that threaten their existence. Scientists have known for years that brook trout—an ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA has requested Atlas to subscribe and pay for an additional tranche ...

University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

“In general, we have not recommended boosters because there is no clear evidence that people need it. But there probably is ...

Mice are still incapable of writing the complete works of Shakespeare, despite some being given a human "language gene".